ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis
Europe - BIT:1ANTM - US0367521038 - Common Stock
304.2 EUR
+2.7 (+0.9%)
1ANTM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. 1ANTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ANTM has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
1ANTM had positive earnings in the past year.
In the past year 1ANTM had a positive cash flow from operations.
In the past 5 years 1ANTM has always been profitable.
1ANTM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.40%, 1ANTM is doing good in the industry, outperforming 77.14% of the companies in the same industry.
The Return On Equity of 1ANTM (12.26%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 5.90%, 1ANTM perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1ANTM is in line with the industry average of 5.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROIC | 5.9% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
1ANTM has a Profit Margin of 2.83%. This is comparable to the rest of the industry: 1ANTM outperforms 57.14% of its industry peers.
In the last couple of years the Profit Margin of 1ANTM has declined.
With a Operating Margin value of 4.60%, 1ANTM perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
1ANTM's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ANTM is destroying value.
The number of shares outstanding for 1ANTM has been reduced compared to 1 year ago.
1ANTM has less shares outstanding than it did 5 years ago.
1ANTM has a worse debt/assets ratio than last year.
2.2 Solvency
1ANTM has a debt to FCF ratio of 5.70. This is a neutral value as 1ANTM would need 5.70 years to pay back of all of its debts.
The Debt to FCF ratio of 1ANTM (5.70) is better than 71.43% of its industry peers.
1ANTM has a Debt/Equity ratio of 0.65. This is a neutral value indicating 1ANTM is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.65, 1ANTM is doing good in the industry, outperforming 74.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Altman-Z | N/A |
ROIC/WACC0.73
WACC8.12%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
1ANTM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.64%.
Measured over the past years, 1ANTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
Looking at the last year, 1ANTM shows a quite strong growth in Revenue. The Revenue has grown by 10.21% in the last year.
The Revenue has been growing by 11.14% on average over the past years. This is quite good.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
3.2 Future
1ANTM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.89% yearly.
Based on estimates for the next years, 1ANTM will show a quite strong growth in Revenue. The Revenue will grow by 8.96% on average per year.
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.76, the valuation of 1ANTM can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of 1ANTM indicates a rather cheap valuation: 1ANTM is cheaper than 82.86% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.19, 1ANTM is valued rather cheaply.
A Price/Forward Earnings ratio of 11.27 indicates a reasonable valuation of 1ANTM.
Based on the Price/Forward Earnings ratio, 1ANTM is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.50. 1ANTM is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.76 | ||
| Fwd PE | 11.27 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ANTM is on the same level as its industry peers.
1ANTM's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.12 | ||
| EV/EBITDA | 9.95 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.96
EPS Next 2Y-2.2%
EPS Next 3Y3%
5. Dividend
5.1 Amount
1ANTM has a Yearly Dividend Yield of 1.96%.
Compared to an average industry Dividend Yield of 2.53, 1ANTM pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, 1ANTM has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
5.2 History
On average, the dividend of 1ANTM grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
28.40% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
1ANTM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y-2.2%
EPS Next 3Y3%
BIT:1ANTM (10/10/2025, 7:00:00 PM)
304.2
+2.7 (+0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap68.50B
Revenue(TTM)189.25B
Net Income(TTM)5.36B
Analysts76.43
Price Target317.97 (4.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
Yearly Dividend5.61
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)-24.27%
PT rev (3m)-34.19%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)-42.5%
EPS NY rev (1m)-13.11%
EPS NY rev (3m)-12.64%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.76 | ||
| Fwd PE | 11.27 | ||
| P/S | 0.42 | ||
| P/FCF | 15.12 | ||
| P/OCF | 12.48 | ||
| P/B | 1.83 | ||
| P/tB | 20.71 | ||
| EV/EBITDA | 9.95 |
EPS(TTM)28.27
EY9.29%
EPS(NY)27
Fwd EY8.87%
FCF(TTM)20.12
FCFY6.61%
OCF(TTM)24.37
OCFY8.01%
SpS719.51
BVpS166.22
TBVpS14.69
PEG (NY)N/A
PEG (5Y)0.96
Graham Number325.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROCE | 7.72% | ||
| ROIC | 5.9% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 11.77% | ||
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A | ||
| FCFM | 2.8% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 75.47% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.96% | ||
| Profit Quality | 98.73% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACC8.12%
ROIC/WACC0.73
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.53%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / 1ANTM.MI FAQ
What is the ChartMill fundamental rating of ELEVANCE HEALTH INC (1ANTM.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to 1ANTM.MI.
What is the valuation status for 1ANTM stock?
ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (1ANTM.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for ELEVANCE HEALTH INC?
ELEVANCE HEALTH INC (1ANTM.MI) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ELEVANCE HEALTH INC (1ANTM.MI) stock?
The Price/Earnings (PE) ratio for ELEVANCE HEALTH INC (1ANTM.MI) is 10.76 and the Price/Book (PB) ratio is 1.83.
Can you provide the financial health for 1ANTM stock?
The financial health rating of ELEVANCE HEALTH INC (1ANTM.MI) is 3 / 10.